Diabetes

This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.

A Midwest pharmacy chain is creating an adherence program to help its patients with diabetes.

How a diabetes clinic that includes a collaboration between an endocrinologist and a pharmacist can produce thousands of dollars in health-care savings.

People with diabetes and health-care professionals have more options for managing their care as more companies create high-tech tools for them. Now, three recently-launched tools and apps will provide more help to pharmacists so that they can help people with diabetes in managing their disease.

A study has found that patients with diabetes at a rural clinic have improved health outcomes when they are managed by a pharmacist diabetes clinic.

Here's how this pharmacy chain is helping patients with diabetes better manage their disease.

Here's a quick overview of new drugs, a novel device that can replace fingersticks, and an “artificial pancreas” meant to make life easier for patients with diabetes.

When pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples.

Despite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.

Barton Health recently began using digital sensors compounded in medications to provide insights about medication use for patients dealing with uncontrolled and co-morbid hypertension.

The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.

Since they see diabetic patients so often, community pharmacists who encourage vaccination can play a major role in boosting public health.

If you are a pharmacist who deals with patients, expect to deal with gestational diabetes.

Type 2 diabetes is associated with a two- to four-fold increase in the risk of CVD. Pharmacists can monitor and manage the risk factors.

Pharmacists who provide remote monitoring of three chronic disease states can help patients improve health targets

FDA has approved two long-acting insulins by Novo Nordisk for the treatment of adults with diabetes mellitus.

Diabetes patients taking rosiglitazone or pioglitazone had a 28 percent lower incidence of Parkinson's disease (PD) than people taking other treatments for diabetes who had never taken the glitazone (GTZ) drugs, according to a new study.

The American Pharmacists Association Foundation has introduced a self-management tool designed to improve healthcare outcomes for diabetes patients and to reduce overall costs.

When it comes to using plain language, clearly displaying content, and engaging users, paid mobile applications for managing diabetes are more useful than free ones, according to a study published by the Centers for Disease Control and Prevention.

Interventions between Canadian pharmacists and patients who returned for follow-up improved diabetes outcomes significantly, according to a recently released study.

To discourage the spread of infection, FDA has ordered manufacturers of multi-dose insulin pens to display the warning “For single patient use only” on all materials connected with the products.

Many patients have diabetes for between 10 and 20 years or more before DR develops, so the key to managing ocular complications in patients with diabetes is regular evaluations.

Which comes first, diabetes or depression? While the connection is recognized, the answer is not yet certain.

The American Diabetes Association (ADA) is calling for all patients with diabetes who are at high risk for cardiovascular disease (CVD) to be treated with statins and lifestyle therapy, according to its recently published guidance in the January issue of Diabetes Care.

Pharmacists delivering patient care services as part of patient-centered, interdisciplinary healthcare teams can make a difference for diabetes patients who are disproportionately affected by the disease and have limited access to quality care, according to the final results of Project IMPACT: Diabetes.